Abstract
This paper is dealing with how much investment is invested in Research and development before TRIPs and after TRIPs, here we are focusing on the pharmaceutical industries, looking into the differences in outcomes and also analyse the impact of this investment with the help of Schumpeter’s Theory. Analysing those with the help of data’s given shows that there is no high difference in spending on Research and Development before and after the TRIPs.
This is an Open Access article distributed under the terms of the Creative Commons Attribution–NonCommercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting, and building upon the work for non-commercial use, provided the original work is properly cited.